122 0551

Drug Profile

122 0551

Alternative Names: Topical corticosteroid - Therapeutics Incorporated

Latest Information Update: 07 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Therapeutics Incorporated
  • Class Corticosteroids; Skin disorder therapies; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Plaque psoriasis

Most Recent Events

  • 16 Jun 2017 Therapeutics completes the phase III Study 310 trial for Plaque psoriasis in USA (NCT02742441)
  • 01 Feb 2017 Therapeutics completes two phase III trials in Plaque psoriasis in USA (NCT02368210, NCT02367911)
  • 01 Jun 2016 Therapeutics initiates enrolment in the Study 310 trial for Plaque psoriasis in USA (NCT02742441)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top